SCIMEA Sets up the Special Committee on Heart Rhythm

On March 12, 2021, the inaugural meeting of the Special Committee on Heart Rhythm of Sichuan International Medical Exchange & Promotion Association (“SCIMEA”) was successfully held at the Renaissance ....

2021-03-26

A U.S. Academician Joins MedComm as an Editor-in-Chief

Now MedComm is privileged to have Prof. Günter P. Wagner, a U.S. Academician as an Editor-in-Chief.

2021-03-26

MedComm

 
A National Advanced Collective in Fighting against the COVID-19 Epidemic! Thumb up to West China Hospital and its medical staff

On the morning, a meeting was held at the Great Hall of the People to commend role models in the country's fight against the COVID-19 epidemic.

2021-03-19

Fight against the COVID-19 Together | West China-Mayo International Forum of Critical Care Medicine 2020 Held in Chengdu

On November 19, 2020, the “West China-Mayo International Forum of Critical Care Medicine 2020”, hosted by Sichuan Preventive Medicine Association, Sichuan International Medical Exchange & Promotion As

2021-03-22

SCIMEA Wins the Award of “The Most Influential Academic Activity of the Year in Sichuan and Chongqing”

On December 10, the first Sichuan and Chongqing Science and Technology Academic Conference and Sichuan Science and Technology Academic Conference kicked off in Chengdu.

2021-03-22

Speed up the Commercialization of COVID-19 Vaccines!

Chengdu High-Tech Zone, Shanghai Pharmaceuticals and Wesker sign an agreement to build Tianfu Vaccine Valley and create a full-chain vaccine industry

2021-03-19

The Phase II Clinical Trial of the Recombinant Protein COVID-19 Vaccine Kicks off

It is reported that the phase II clinical trial of the recombinant protein COVID-19 vaccine (Sf9 cell) from West China Hospital of Sichuan University/Chengdu Wesker Biomedical Co., Ltd.

2021-03-16

Chengdu Wesker Raises Approximately 300 million yuan in Series A Financing for Vaccine Research

On November 16, the signing ceremony for investment in Wesker, co-sponsored by Chengdu Wesker Biomedical Co., Ltd., Sichuan Development Holding Co., Ltd. and Shanghai Pharmaceuticals Holding Co., Ltd.

2021-03-16

The First Insect Cell-Grown Recombinant Protein COVID-19 Vaccine Injected in Volunteers

On August 28, 2020, the phase I clinical trial of the recombinant protein COVID-19 vaccine (Sf9 cell) of West China Hospital, Sichuan University kicked off its training effort in China Medical City

2021-03-15